Beverly A. Teicher - Concepedia

Author

Beverly A. Teicher

Dana-Farber Cancer Institute

Also Known As

B A Teicher, B Teicher, B.A. Teicher, Beverly A. Teicher

Publications

802

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Brigham and Women's Hospital Beth Israel Deaconess Hospital Harvard University

About

Beverly A. Teicher is an author at Dana-Farber Cancer Institute specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	717
2	Biochemistry	7	7	270
3	Health Sciences	5	5	172
4	Natural Sciences	4	4	158
5	Biomolecular Engineering	1	1	10

Beverly A. Teicher

Publications

751

Citations

H-Index

Page 1

	Year	Citations
Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum(II). Alakananda Basu, Beverly A. Teicher, John S. Lazo Journal of Biological Chemistry Molecular RegulationCell DeathCellular PharmacologyHela CellsCellular Physiology	1990	92
Glutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamide Beverly A. Teicher, James M. Crawford, Sylvia A. Holden, Cancer PathologyPharmacotherapyDrug ResistanceToxicologyHepatotoxicity	1988	85
Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models Roy S. Herbst, Hideya Takeuchi, Beverly A. Teicher Cancer Chemotherapy and Pharmacology OncologyMedicineBreast Carcinoma ModelsBronchial NeoplasmPaclitaxel/carboplatin Administration	1998	69
A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity. J P Eder, C Wheeler, Beverly A. Teicher, PubMed PathologyPharmacotherapyAntimicrobial ChemotherapyAgent CytotoxicityCancer Chemotherapy	1991	58
Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts. Beverly A. Teicher, Krishna Menon, Enrique Álvarez, PubMed PathologyHigh-grade GliomasMetronomic ChemotherapyCancer BiologyGlioma	2001	58
Development of alkylating agent-resistant human tumor cell lines Beverly A. Teicher, Emil Frei Cancer Chemotherapy and Pharmacology Tumor BiologyMedicineTumor TargetingAnti-cancer AgentCancer Biology	1988	47
Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N,N',N''-triethylenethiophosphoramide. Beverly A. Teicher, David J. Waxman, S A Holden, PubMed Antitumor ActivityChemoprevention StrategyTumor Growth DelayCell DeathRedox Biology	1989	46
Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents. J P Eder, Beverly A. Teicher, S A Holden, PubMed Antitumor ActivityImmunologyPharmacotherapyAntimicrobial ChemotherapyMetronomic Chemotherapy	1989	40
Effect of Fluosol-DA® on the response of intracranial 9L tumors to X rays and BCNU Beverly A. Teicher, Terence S. Herman, Christopher M. Rose International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyRadiation TherapyMedicineRadiopharmaceutical TherapyNeurology	1988	28
Apoptosis and Clonogenic Cell Death in PC3 Human Prostate Cancer Cells after Treatment with Gamma Radiation and Suramin Sanjeewani T. Palayoor, Edward A. Bump, Beverly A. Teicher, Radiation Research UrologyRadiation-induced ApoptosisRadiation TherapyDna FragmentationMedicine	1997	28

Page 1